|
M.A. Darenskaya, E.V. Chugunova, S.I. Kolesnikov, L.A. Grebenkina, N.V. Semenova, O.A. Nikitina, L.I. Kolesnikova
Indicators of endogenous intoxication and lipid peroxidation in the dynamics of treatment with α-lipoic acid in men with diabetic nephropathy at the stage of microalbuminuria
|
№3 / 2021
|
|
A.A. Ilyushkina, G.V. Baydakova, I.O. Bychkov, N.A. Buruleva, E.Yu. Zakharova
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
|
№2 / 2020
|
|
M.V. Amosova, O.Yu. Gurova
Kidney damage in type 2 diabetes mellitus: is it diabethic nephropathy only?
|
№4 / 2017
|
|
E.S. Krutikov, S.I. Chistjakova, V.A. Cvetkov
Characteristic features of intrarenal blood flow in patients with essential hypertension and preclinical hypertensive nephropathy
|
№5-6 / 2015
|
|
E.S. Krutikov, S.I. Chistyakova.
Peculiarities of functioning of the kidneys in overweight patients with essential hypertension
|
№5 / 2014
|
|
E.Yu. Ponomareva, M.A. Tiapkina, A.P. Rebrov
Renal disease in infective endocarditis in intravenous drug users: clinical characteristics and tubulo-interstitial damage
|
№4 / 2013
|
|
M.V. Kudin
Enzymuria in children with nephropathies from district with cement manufacture
|
№2 / 2012
|
|
V.V. Fomin, A.A. Pulin, V.V. Rameev, V.P. Sedov, A.D. Meshkov, S.V. Roschupkina, V.V. Panasiuk, L.V. Kozlovskaya, N.A. Moukhin
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
|
№5 / 2010
|
|
V.V. Fomin, E.A. Saginova
Aliskiren – direct renin inhibitor in treatment of cardio-renal syndrome in patients with metabolic syndrome and obesity
|
№4 / 2010
|
|
E.A. Saginova, M.G. Gallyamov, M.M. Severova
Update on renal affection in obesity
|
№2 / 2010
|
Русский
